Arrowstreet Capital’s Vanda Pharmaceuticals VNDA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.67M	Buy	+241,430	New	+$1.86M	﹤0.01%	1441
2023 Q4	–	Sell	-29,778	Closed	-$129K	–	1567
2023 Q3	$129K	Buy	+29,778	New	+$165K	﹤0.01%	1213
2022 Q2	–	Sell	-101,763	Closed	-$1.15M	–	1443
2022 Q1	$1.15M	Sell	101,763 -162,766	-62%	-$2.14M	﹤0.01%	910
2021 Q4	$4.15M	Sell	264,529 -77,714	-23%	-$1.35M	0.01%	859
2021 Q3	$5.87M	Sell	342,243 -79,179	-19%	-$1.39M	0.01%	897
2021 Q2	$9.06M	Buy	+421,422	New	+$7.54M	0.01%	870
2019 Q2	–	Sell	-52,559	Closed	-$967K	–	1724
2019 Q1	$967K	Buy	+52,559	New	+$1.2M	﹤0.01%	1328
2017 Q2	–	Sell	-86,389	Closed	-$1.21M	–	1350
2017 Q1	$1.21M	Buy	+86,389	New	+$1.23M	﹤0.01%	930
2013 Q4	–	Sell	-13,044	Closed	-$143K	–	1301
2013 Q3	$143K	Buy	+13,044	New	+$139K	﹤0.01%	940